TY - JOUR KW - Public Health, Environmental and Occupational Health KW - Parasitology KW - Infectious Diseases KW - General Medicine KW - Neglected tropical diseases (NTDs) AU - Molyneux DH AU - Asamoa-Bah A AU - Fenwick A AU - Savioli L AU - Hotez P AB - Abstract The history of the neglected tropical disease movement is seen through the lens of authors who worked during the last 4 decades in different roles and in different settings, from Western-based laboratories to clinical roles in endemic countries and in critical policy roles in the World Health Organization (WHO). The authors seek to identify key players from the introduction of the word ‘neglected’ by the late Kenneth Warren in his Rockefeller Foundation–supported Great Neglected Diseases of Mankind movement through to the more recent developments after the London Declaration of 2012. The role of the various actors—endemic countries, major pharmaceutical companies, the WHO, non-government development organizations, bilateral donors and academia—are discussed. The critical events and decisions are highlighted that were essential enabling factors in creating a viable and successful movement and with a resultant massive global public health and antipoverty impact. The importance of advocacy is emphasized in creating the momentum to establish a globally recognized public health ‘brand’ as a target in the United Nations Sustainable Development Goals. BT - Transactions of The Royal Society of Tropical Medicine and Hygiene DO - 10.1093/trstmh/trab015 IS - 2 LA - eng N2 - Abstract The history of the neglected tropical disease movement is seen through the lens of authors who worked during the last 4 decades in different roles and in different settings, from Western-based laboratories to clinical roles in endemic countries and in critical policy roles in the World Health Organization (WHO). The authors seek to identify key players from the introduction of the word ‘neglected’ by the late Kenneth Warren in his Rockefeller Foundation–supported Great Neglected Diseases of Mankind movement through to the more recent developments after the London Declaration of 2012. The role of the various actors—endemic countries, major pharmaceutical companies, the WHO, non-government development organizations, bilateral donors and academia—are discussed. The critical events and decisions are highlighted that were essential enabling factors in creating a viable and successful movement and with a resultant massive global public health and antipoverty impact. The importance of advocacy is emphasized in creating the momentum to establish a globally recognized public health ‘brand’ as a target in the United Nations Sustainable Development Goals. PB - Oxford University Press (OUP) PY - 2021 SP - 169 EP - 175 T2 - Transactions of The Royal Society of Tropical Medicine and Hygiene TI - The history of the neglected tropical disease movement UR - https://academic.oup.com/trstmh/article-pdf/115/2/169/36129949/trab015.pdf VL - 115 SN - 0035-9203, 1878-3503 ER -